Global epidemiology and burden of HCV infection and HCV-related disease.
about
Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.Hepatocellular carcinoma: early-stage management challengesHuman Genetic Determinants of Viral Diseases.Disparities in liver cancer occurrence in the United States by race/ethnicity and state.Adiponectin serum level changes and its dynamic relationship with hepatitis C during viral clearance.An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms.Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis.From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China.Regulation of hepatitis C virus replication via threonine phosphorylation of the NS5A protein.Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infection.The dynamic landscape of liver transplant in the era of effective hepatitis C virus therapy.Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects.The hepatitis C viral nonstructural protein 5A stabilizes growth-regulatory human transcripts.Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population.Update on hepatitis C and implications for pregnancy.Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients.Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis.Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C.Biochemical Basis of Vosevi, a New Treatment for Hepatitis CPublished as part of the Biochemistry series "Biochemistry to Bedside".Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.Educational and Behavioral Counseling in a Methadone Maintenance Treatment Program in China: A Randomized Controlled Trial.Dynamic Models of Infectious Disease Transmission in Prisons and the General Population.Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.Interleukin-21 rs2055979 and Interleukin-21 receptor rs3093390 genetic variants and hepatitis C virus chronic infection.Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity.The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.Correlation between Vitamin D3 level and extrahepatic manifestation in chronic hepatitis type-C virus patients.Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012.Nontraditional Cardiovascular Biomarkers and Risk Factors: Rationale and Future Perspectives.The Detection and Phylogenetic Analysis of Bovine Hepacivirus in China.Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formation
P2860
Q33702754-61EF43C2-E7C0-42F7-93D1-F9CF02893591Q33881131-9A6D7E3B-DC2A-4984-AAC3-90A75C943D69Q38635643-B6F8D423-B06E-42DC-87DE-F07C0670F6E1Q38741005-8B87FBEE-6925-4399-A972-D1166E83074FQ38855945-6463EB61-AC21-4361-A67B-BC8F5013CA28Q40055793-39FA464C-456B-4444-A2DC-C233098D817FQ40064478-7C4485DE-568B-4A8C-84E6-8193C10DFD08Q40135838-5926AD59-FED1-45FD-92EC-71CE861DE6FDQ45324124-3941047A-C1F7-4D78-A608-4DF6D967E530Q45324832-369F8350-B2B9-442C-8903-8AF80D7FA6A4Q45325141-BDE183CC-0309-4A99-AAAB-B8A5CD045D68Q45330991-A17C7C96-73CF-4FA9-9926-839C0F12B8FDQ47278098-858826E9-C0CD-4FF0-B497-199F54EFFBE9Q47547598-956262FB-368D-4D5A-A0E6-C85603E848D5Q47552631-1AE323B2-4FCD-4883-A623-0D2BEE0B5D8CQ47564118-36E4D905-5091-45BB-8734-5C3F97209D9DQ47567433-9535E1EB-4277-42B3-9643-B9380F40F9B0Q47577278-152C92FB-0544-4864-BBE0-2DA8D15F206AQ47591332-C1A471A7-B922-41C8-838E-11A8CC53921FQ48044962-40BD9418-2E14-4D10-A926-585FCFD9B919Q48218532-4F2C1F0E-E2ED-4CF2-B51B-B2E69377B277Q49232850-D355ED4B-9BF0-4A78-9BB0-227CB141CB59Q52318028-866A034D-8BEC-4C7B-8503-551E1C02C97EQ52642656-2DDAB040-E92C-4044-978B-643A1EF8CB59Q52655967-1DEFAC40-1F19-489B-AE33-ECCFC19B0A4DQ54462092-88CFE321-7F50-495D-BD58-EDD0589BA3F0Q55029658-9F6BF3E9-5AA1-40DC-AA75-5691E439F85BQ55130392-213F4507-2394-46EF-8035-AD24B540DB9FQ55347848-CED897FC-65F8-4459-8028-792630EC1386Q55360775-EF9B1303-427D-46E1-AC01-30015B1387B9Q55384368-3112523E-F8FF-4C91-91F6-314378B07241Q55465943-042AE63E-B8B3-45A4-8CD4-B375198268E4Q55501318-BB46BD42-3D0B-4233-8B69-CD9CFA05E0D9Q58723536-38591207-868A-4991-AB30-1AAC785EF4F7
P2860
Global epidemiology and burden of HCV infection and HCV-related disease.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Global epidemiology and burden of HCV infection and HCV-related disease.
@ast
Global epidemiology and burden of HCV infection and HCV-related disease.
@en
type
label
Global epidemiology and burden of HCV infection and HCV-related disease.
@ast
Global epidemiology and burden of HCV infection and HCV-related disease.
@en
prefLabel
Global epidemiology and burden of HCV infection and HCV-related disease.
@ast
Global epidemiology and burden of HCV infection and HCV-related disease.
@en
P2093
P2860
P1476
Global epidemiology and burden of HCV infection and HCV-related disease.
@en
P2093
Aaron P Thrift
Fasiha Kanwal
Hashem B El-Serag
P2860
P2888
P304
P356
10.1038/NRGASTRO.2016.176
P407
P577
2016-12-07T00:00:00Z
P6179
1008888286